Twelve-step programs have millions of recovering members worldwide, yet they’re often dismissed by academics. Why?
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored by President Donald Trump’s administration is causing alarm across the ...